Bone marrow-derived progenitor cells in cerebral autosomal dominant arteriopathy with subcortical infarcts and

Francesca Pescini1, Francesca Cesari, Betti Giusti

  • 1Department of Neurological and Psychiatric Sciences, Thrombosis Center, University of Florence, Florence, Italy. francescapescini@virgilio.it

Stroke
|December 26, 2009
PubMed

Insights

Patients with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) have significantly lower levels of endothelial progenitor cells. Circulating progenitor cells (CPCs) were reduced in CADASIL patients with stroke or dementia, correlating with cognitive and motor performance.

Area of Science:

  • Neuroscience
  • Vascular Biology
  • Regenerative Medicine

Background:

  • Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a genetic small vessel disease causing stroke and cognitive decline.
  • The precise mechanisms linking vascular changes to brain damage in CADASIL are not fully understood, with endothelial dysfunction being a key hypothesis.
  • Endothelial progenitor cells (EPCs) and circulating progenitor cells (CPCs) are crucial for maintaining vascular health and repair.

Purpose of the Study:

  • To investigate the role of endothelial progenitor cells (EPCs) and circulating progenitor cells (CPCs) in CADASIL.
  • To determine if levels of these progenitor cells differ between CADASIL patients and healthy controls.
  • To explore the association between progenitor cell levels and clinical manifestations in CADASIL.

Main Methods:

  • Flow cytometry was used to quantify EPCs and CPCs in the peripheral blood of 29 CADASIL patients and 29 age- and sex-matched controls.
  • EPCs were identified as CD34/KDR, CD133/KDR, and CD34/CD133/KDR positive cells.
  • CPCs were identified as CD34, CD133, and CD34/CD133 positive cells.

Main Results:

  • Patients with CADASIL exhibited significantly lower levels of all measured endothelial progenitor cell (EPC) subtypes compared to controls.
  • Circulating progenitor cell (CPC) levels were not significantly different in CADASIL overall, but were markedly reduced in patients with stroke or dementia.
  • Reduced CPC levels correlated significantly with poorer cognitive and motor performance measures in CADASIL patients.

Conclusions:

  • This study demonstrates a significant association between reduced endothelial progenitor cells and CADASIL.
  • The findings support the hypothesis of endothelial dysfunction playing a role in CADASIL pathogenesis.
  • Circulating progenitor cell levels may serve as a biomarker for disease severity and clinical outcomes in CADASIL.
Abstract

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...